About Tiny Cargo
Located at 315 Albemarle Avenue Southeast in Roanoke, Virginia, the cosmetic lab at Tiny Cargo Company pioneers milk exosomes research and development. From its state-of-the-art facility, the lab offers:
- Industrial-scale milk exosome isolation
- Novel drug delivery platform development
- Radiation protection research
- Medical countermeasure development
With BARDA approval and the upcoming launch of their Xolacta platform in 2024, Tiny Cargo Company leads biomedical innovation in the southeastern United States.
Frequently asked questions
Tiny Cargo Company focuses on these biomedical applications:
- Drug Delivery Platform
- Xolacta technology platform
- Milk exosome isolation
- Therapeutic loading systems
- Medical Applications
- Infant development products
- Muscle recovery solutions
- Gastrointestinal health products
- Radiation Protection
- Radiation exposure treatments
- Cancer therapy protection
- Medical countermeasures
Tiny Cargo Company works with these technologies:
| Technology | Applications |
|---|---|
| Milk Exosomes |
|
| Drug Delivery |
|
| Regulatory Status |
|
The company operates through multiple channels:
- Research Facilities
- Biomedical engineering labs
- Industrial scale production units
- Quality control centers
- Development Areas
- Pharmaceutical research
- Nutraceutical production
- Clinical testing facilities
Production Timeline:
| Phase | Timeline |
|---|---|
| Research Phase | Completed |
| Industrial Scale Production | Late 2024 |
| Commercial Distribution | Pending |
More details about Tiny Cargo
Pioneering biomedical research in Virginia
Located in Roanoke, Virginia, Tiny Cargo Company operates a cosmetic lab and research facility focused on advancing milk exosomes technology. Since its establishment, the company has positioned itself at the forefront of exosome research and applications.
Innovative research and development
At 315 Albemarle Avenue Southeast, our facility combines advanced laboratory capabilities with industrial-scale production methods. The company stands as the first in the United States to successfully isolate exosomes from cow’s milk at an industrial scale, with commercial production set to begin in late 2024.
Specialized services and applications
- Development of the Xolacta drug delivery platform
- Research in radiation protection treatments
- Nutraceutical development and testing
- Pharmaceutical compound integration
Medical and therapeutic solutions
The company’s research focuses on multiple health applications, including infant development, muscle recovery, bone health, and gastrointestinal wellness. Our work with exosomes leverages their natural properties, including their stable lipid bilayer membrane and high biocompatibility.
Advancing cancer treatment protocols
The Roanoke facility conducts research on radiation protection, developing treatments for radiation exposure and exploring ways to protect healthy cells during cancer treatments. This work has earned recognition from BARDA, receiving approval for additional medical countermeasure trials.
Technology and innovation center
Our Virginia-based laboratory combines biomedical engineering expertise with pharmaceutical development capabilities. The facility specializes in cellular signaling research and therapeutic applications, contributing to the growing biotech sector in the Southeast United States.
Company gallery
